0001078782-18-001444.txt : 20181221 0001078782-18-001444.hdr.sgml : 20181221 20181221162610 ACCESSION NUMBER: 0001078782-18-001444 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181220 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Skaff Habib CENTRAL INDEX KEY: 0001620124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36833 FILM NUMBER: 181249851 MAIL ADDRESS: STREET 1: 4006 W. SWANN AVENUE CITY: TAMPA STATE: FL ZIP: 33609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 SCOTTS RD #24-05 SHAW CENTRE CITY: SINGAPORE STATE: U0 ZIP: 228208 BUSINESS PHONE: 1 (646) 650-1351 MAIL ADDRESS: STREET 1: 1 SCOTTS RD #24-05 SHAW CENTRE CITY: SINGAPORE STATE: U0 ZIP: 228208 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-12-20 0 0000093314 VOLITIONRX LTD VNRX 0001620124 Skaff Habib 4006 W. SWANN AVENUE TAMPA FL 33609 1 0 0 0 Option (Right to Buy) 2.5 2018-12-20 4 D 0 12500 0 D 2015-02-18 2019-02-18 Common Stock 12500 0 D Option (Right to Buy) 3 2018-12-20 4 D 0 12500 0 D 2016-02-18 2020-02-18 Common Stock 12500 0 D Option (Right to Buy) 2.5 2018-12-20 4 A 0 12500 0 A 2015-02-18 2020-08-18 Common Stock 12500 12500 D Option (Right to Buy) 3 2018-12-20 4 A 0 12500 0 A 2016-02-18 2020-08-18 Common Stock 12500 12500 D Option (Right to Buy) 4 2018-12-20 4 D 0 10000 0 D 2016-01-23 2020-01-23 Common Stock 10000 0 D Option (Right to Buy) 4 2018-12-20 4 A 0 10000 0 A 2016-01-23 2021-07-23 Common Stock 10000 10000 D The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021. /s/ Habib Skaff 2018-12-21